How Good is MRI at Detecting and Characterising Cancer within the Prostate?

European Urology

Volumn 50, Issue 6, 2006, Pages 1163-1175

  Kirkham, Alexander P S ^a   Emberton, Mark ^b   Allen, Clare ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Magnetic resonance imaging; Prostate cancer

Indexed keywords

CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CANCER SIZE; CANCER THERAPY; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; GLEASON SCORE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM BIOPSY; REVIEW; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 33750609192     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.06.025     Document Type: Review

References (79)

1. Engelbrecht M.R., Jager G.J., Laheij R.J., Verbeek A.L., van Lier H.J., and Barentsz J.O. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12 (2002) 2294-2302
2. Sonnad S.S., Langlotz C.P., and Schwartz J.S. Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change. Acad Radiol 8 (2001) 49-57
3. Djavan B., Ravery V., Zlotta A., et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?. J Urol 166 (2001) 1679-1683
4. Zackrisson B., Aus G., Bergdahl S., et al. The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable. J Urol 171 (2004) 1500-1503
5. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
6. Furuno T., Demura T., Kaneta T., et al. Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate 58 (2004) 76-81
7. Steineck G., Helgesen F., Adolfsson J., et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347 (2002) 790-796
8. Onik G., Narayan P., Vaughan D., Dineen M., and Brunelle R. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 60 (2002) 109-114
9. Djavan B., Susani M., Bursa B., Basharkhah A., Simak R., and Marberger M. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. Tech Urol 5 (1999) 139-142
10. Huidobro C., Bolmsjo M., Larson T., et al. Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping. J Urol 171 (2004) 672-678
11. Onik G. The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review. Technol Cancer Res Treat 3 (2004) 365-370
12. Uchida T., Ohkusa H., Nagata Y., Hyodo T., Satoh T., and Irie A. Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int 97 (2006) 56-61
13. Moore C.M., Hoh I.M., Bown S.G., and Emberton M. Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?. BJU Int 96 (2005) 754-758
14. Steinberg D.M., Sauvageot J., Piantadosi S., and Epstein J.I. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 21 (1997) 566-576
15. Padhani A.R., Gapinski C.J., Macvicar D.A., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 (2000) 99-109
16. Rouviere O., Raudrant A., Ecochard R., et al. Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13 (2003) 931-942
17. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 203 (1997) 645-652
18. Cruz M., Tsuda K., Narumi Y., et al. Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol 12 (2002) 357-365
19. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 (1999) 473-480
20. Quint L.E., Van Erp J.S., Bland P.H., et al. Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume. AJR Am J Roentgenol 156 (1991) 511-516
21. Hricak H., White S., Vigneron D., et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 193 (1994) 703-709
22. Noguchi M., Stamey T.A., Neal J.E., and Yemoto C.E. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 163 (2000) 1751-1755
23. McNeal J.E., Redwine E.A., Freiha F.S., and Stamey T.A. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12 (1988) 897-906
24. Ellis J.H., Tempany C., Sarin M.S., Gatsonis C., Rifkin M.D., and McNeil B.J. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR Am J Roentgenol 162 (1994) 865-872
25. Ikonen S., Karkkainen P., Kivisaari L., et al. Magnetic resonance imaging of clinically localized prostatic cancer. J Urol 159 (1998) 915-919
26. Akin O., Sala E., Moskowitz C.S., et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 293 (2006) 784-792
27. Mirowitz S.A., Brown J.J., and Heiken J.P. Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging. Radiology 186 (1993) 153-157
28. Turnbull L.W., Buckley D.L., Turnbull L.S., Liney G.P., and Knowles A.J. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology. J Magn Reson Imaging 9 (1999) 311-316
29. Preziosi P., Orlacchio A., Di Giambattista G., et al. Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 13 (2003) 925-930
30. Padhani A.R. MRI for assessing antivascular cancer treatments. Br J Radiol 76 (2003) S60-S80
31. Kiessling F., Lichy M., Grobholz R., et al. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI. Eur Radiol 14 (2004) 1793-1801
32. Schlemmer H.P., Merkle J., Grobholz R., et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?. Eur Radiol 14 (2004) 309-317
33. Ito H., Kamoi K., Yokoyama K., Yamada K., and Nishimura T. Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. Br J Radiol 76 (2003) 617-624
34. Hara N., Okuizumi M., Koike H., Kawaguchi M., and Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62 (2005) 40-47
35. Ogura K., Maekawa S., Okubo K., et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 57 (2001) 721-726
36. Muramoto S., Uematsu H., Kimura H., et al. Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging. Eur J Radiol 44 (2002) 52-58
37. Coakley F.V., Qayyum A., and Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol 170 (2003) S69-S75 discussion S75-66
38. Wefer A.E., Hricak H., Vigneron D.B., et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164 (2000) 400-404
39. Zakian K.L., Eberhardt S., Hricak H., et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. Radiology 229 (2003) 241-247
40. Parivar F., Hricak H., Shinohara K., et al. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 48 (1996) 594-599
41. Pucar D., Shukla-Dave A., Hricak H., et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 236 (2005) 545-553
42. Kurhanewicz J., Swanson M.G., Nelson S.J., and Vigneron D.B. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16 (2002) 451-463
43. Rouviere O., Hartman R.P., and Lyonnet D. Prostate MR imaging at high-field strength: evolution or revolution?. Eur Radiol 16 (2006) 276-284
44. Gibbs P., Tozer D.J., Liney G.P., and Turnbull L.W. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 46 (2001) 1054-1058
45. Hosseinzadeh K., and Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20 (2004) 654-661
46. Sato C., Naganawa S., Nakamura T., et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21 (2005) 258-262
47. Namiki T., Koyama K., Tanaka H., Ohmura M., Harada J., and Fukuda K. Effect of diffusion-weighted imaging with very high b-factors for detection of prostate cancer. Proceedings of the Radiological Society of North America annual meeting, Chicago, 2005 (2005) 649
48. Griffiths J.R., Taylor N.J., Howe F.A., et al. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 39 (1997) 697-701
49. Diergarten T., Martirosian P., Kottke R., et al. Functional characterization of prostate cancer by integrated magnetic resonance imaging and oxygenation changes during carbogen breathing. Invest Radiol 40 (2005) 102-109
50. Nakashima J., Tanimoto A., Imai Y., et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 64 (2004) 101-105
51. Kahn T., Burrig K., Schmitz-Drager B., Lewin J.S., Furst G., and Modder U. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. Radiology 173 (1989) 847-851
52. Sommer F.G., Nghiem H.V., Herfkens R., McNeal J., and Low R.N. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil. AJR Am J Roentgenol 161 (1993) 81-86
53. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166 (1996) 845-852
54. Coakley F.V., Kurhanewicz J., Lu Y., et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223 (2002) 91-97
55. Eichelberger L.E., Koch M.O., Daggy J.K., Ulbright T.M., Eble J.N., and Cheng L. Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer. Am J Clin Pathol 120 (2003) 386-391
56. Zakian K.L., Sircar K., Hricak H., et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234 (2005) 804-814
57. Ikonen S., Karkkainen P., Kivisaari L., et al. Magnetic resonance imaging of prostatic cancer: does detection vary between high and low Gleason score tumors?. Prostate 43 (2000) 43-48
58. Roy C., Sauer B., Tetekpor S., Lang H., Saussine C., and Jacqmin D. Endorectal-MR features of high-grade prostatic intraepithelial neoplasia in the peripheral zone: a retrospective study with pathological correlation. Proceedings of the Radiological Society of North America annual meeting, Chicago, 2005 (2005) 418-419
59. Mydlo J.H., Kral J.G., Volpe M., Axotis C., Macchia R.J., and Pertschuk L.P. An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer. Preliminary results and therapeutic implications. Eur Urol 34 (1998) 426-432
60. Dugan J.A., Bostwick D.G., Myers R.P., Qian J., Bergstralh E.J., and Oesterling J.E. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 275 (1996) 288-294
61. Vilanova J.C., Comet J., Capdevila A., et al. The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients. Eur Radiol 11 (2001) 229-235
62. Comet-Batlle J., Vilanova-Busquets J.C., Saladié-Roig J.M., Gelabert-Mas A., and Barceló-Vidal C. The value of endorectal MRI in the early diagnosis of prostate cancer. Eur Urol 44 (2003) 201-207 discussion 207-8
63. Yuen J.S., Thng C.H., Tan P.H., et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 171 (2004) 1482-1486
64. Husband J.E., Padhani A.R., MacVicar A.D., and Revell P. Magnetic resonance imaging of prostate cancer: comparison of image quality using endorectal and pelvic phased array coils. Clin Radiol 53 (1998) 673-681
65. Scheenen T.W., Roell S., Heijmink S.W., Schlemmer H.P., Barentsz J.O., and Heerschap A. 3D 1H-MR spectroscopic imaging of the human prostate at 3T without an endorectal coil: a step towards MR screening of prostate cancer?. Proceedings of the Radiological Society of North America annual meeting, Chicago, 2005 (2005) 649
66. Mullerad M., Hricak H., Kuroiwa K., et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174 (2005) 2158-2163
67. Kaji Y., Kurhanewicz J., Hricak H., et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology 206 (1998) 785-790
68. Perrotti M., Han K.R., Epstein R.E., et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol 162 (1999) 1314-1317
69. Prando A., Kurhanewicz J., Borges A.P., Oliveira Jr. E.M., and Figueiredo E. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236 (2005) 903-910
70. Reynier C., Troccaz J., Fourneret P., et al. MRI/TRUS data fusion for prostate brachytherapy. Preliminary results. Med Phys 31 (2004) 1568-1575
71. Beyersdorff D., Winkel A., Hamm B., Lenk S., Loening S.A., and Taupitz M. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 234 (2005) 576-581
72. Rifkin M.D., Zerhouni E.A., Gatsonis C.A., et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 323 (1990) 621-626
73. Parivar F., Rajanayagam V., Waluch V., Eto R.T., Jones L.W., and Ross B.D. Endorectal surface coil MR imaging of prostatic carcinoma with the inversion-recovery sequence. J Magn Reson Imaging 1 (1991) 657-664
74. Carter H.B., Brem R.F., Tempany C.M., et al. Nonpalpable prostate cancer: detection with MR imaging. Radiology 178 (1991) 523-525
75. Quinn S.F., Franzini D.A., Demlow T.A., et al. MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. Radiology 190 (1994) 323-327
76. Sanchez-Chapado M., Angulo J.C., Ibarburen C., et al. Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. Eur Urol 32 (1997) 140-149
77. Ponchietti R., Di Loro F., Fanfani A., and Amorosi A. Estimation of prostate cancer volume by endorectal coil magnetic resonance imaging vs. pathologic volume. Eur Urol 35 (1999) 32-35
78. McSherry S.A., Levy F., Schiebler M.L., Keefe B., Dent G.A., and Mohler J.L. Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging. J Urol 146 (1991) 85-89
79. Lencioni R., Menchi I., Paolicchi A., Carini M., Amorosi A., and Bartolozzi C. Prediction of pathological tumor volume in clinically localized prostate cancer: value of endorectal coil magnetic resonance imaging. Magma 5 (1997) 117-121